NCT02821286|Unknown
Loading search results
Sponsor study identifier
observational
100
0 countries
N/A
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This project intends the analysis and profiling of specific antibodies against major peanut allergens in peanut allergic individuals and molecular cloning of human antibodies against major peanut allergens.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
June 29, 2016
Actual (reported)July 1, 2016
Actual (reported)December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Analysis and profiling of specific antibodies against major peanut allergens in samples derived from peanut allergic patients.
June 2016 to May 2018
Blood sampling
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The project population includes patients of at least three years of age with a described history of peanut allergy and/or sensitization to peanut allergens (as evidenced by positive skin prick test or allergen-specific IgE testing).
Full blood
First Submitted
June 29, 2016
First Posted
July 1, 2016
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2025
Estimated (date passed)Salvage Peanut Oral Immunotherapy Study
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 20, 2023
Record last verified: 2023-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: